BAAM 2024 Annual REPORT

Take a look at BAAM’s 2024 accomplishments, including the ways in which the Alliance provided critical input to the RBM Partnership, and provided a platform for elevating ideas around the importance of investing in innovation in the fight against malaria.

2021 Malaria Investment case

Combating malaria is good for business. Malaria interventions reduce healthcare costs for companies while improving workers’ productivity. Further, broader investments in malaria control have the potential to unlock higher levels of consumer and household spending, boost market development, offer new growth opportunities, and bring social and reputational benefits to companies. Read BAAM’s Private Sector Malaria Investment Case to learn more.